SHARE
Cancer Therapy - Global Market Outlook (2018-2027)

Cancer Therapy - Global Market Outlook (2018-2027)

4.3 (29 reviews)
Published: May 2020 ID: SMRC19180
4.3 (29 reviews)
Published: May 2020 ID: SMRC19180

1 Executive Summary    
      
2 Preface    
 
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 End User Analysis   
 3.7 Emerging Markets   
 3.8 Impact of Covid-19  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Cancer Therapy Market, By Cancer Type 
 5.1 Introduction   
 5.2 Respiratory/Lung Cancer  
 5.3 Prostate Cancer   
 5.4 Gynecologic Cancer   
 5.5 Gastrointestinal Cancer  
 5.6 Breast Cancer   
 5.7 Blood Cancer   
      
6 Global Cancer Therapy Market, By Treatment Type 
 6.1 Introduction   
 6.2 Targeted Therapy   
 6.3 Immunotherapy   
 6.4 Hormonal Therapy   
 6.5 Chemotherapy   
      
7 Global Cancer Therapy Market, By End User 

 7.1 Introduction   
 7.2 Cancer and Radiation Therapy Centers 
 7.3 Hospitals    
 7.4 Specialty Clinics   
      
8 Global Cancer Therapy Market, By Geography 
 8.1 Introduction   
 8.2 North America   
  8.2.1 US   
  8.2.2 Canada   
  8.2.3 Mexico   
 8.3 Europe    
  8.3.1 Germany   
  8.3.2 UK   
  8.3.3 Italy   
  8.3.4 France   
  8.3.5 Spain   
  8.3.6 Rest of Europe  
 8.4 Asia Pacific   
  8.4.1 Japan   
  8.4.2 China   
  8.4.3 India   
  8.4.4 Australia   
  8.4.5 New Zealand  
  8.4.6 South Korea  
  8.4.7 Rest of Asia Pacific  
 8.5 South America   
  8.5.1 Argentina  
  8.5.2 Brazil   
  8.5.3 Chile   
  8.5.4 Rest of South America 
 8.6 Middle East & Africa  
  8.6.1 Saudi Arabia  
  8.6.2 UAE   
  8.6.3 Qatar   
  8.6.4 South Africa  
  8.6.5 Rest of Middle East & Africa 
      
9 Key Developments    
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers  
 9.3 New Product Launch  
 9.4 Expansions   
 9.5 Other Key Strategies  
      
10 Company Profiling     
 10.1 Pfizer Inc    
 10.2 Novartis AG   
 10.3 Merck & Co Inc   
 10.4 Johnson and Johnson  
 10.5 F. Hoffmann-La Roche AG  
 10.6 Eli Lilly and Company  
 10.7 Bayer AG    
 10.8 AstraZeneca PLC   
 10.9 Amgen Inc  


List of Tables      
1 Global Cancer Therapy Market Outlook, By Region (2017-2027) ($MN)
2 Global Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
3 Global Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
4 Global Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
5 Global Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
6 Global Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
7 Global Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
8 Global Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
9 Global Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
10 Global Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
11 Global Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
12 Global Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
13 Global Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
14 Global Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
15 Global Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
16 Global Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
17 Global Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
18 North America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
19 North America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
20 North America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
21 North America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
22 North America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
23 North America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
24 North America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
25 North America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
26 North America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
27 North America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
28 North America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
29 North America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
30 North America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
31 North America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
32 North America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
33 North America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
34 North America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
35 Europe Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
36 Europe Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
37 Europe Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
38 Europe Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
39 Europe Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
40 Europe Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
41 Europe Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
42 Europe Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
43 Europe Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
44 Europe Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
45 Europe Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
46 Europe Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
47 Europe Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
48 Europe Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
49 Europe Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
50 Europe Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
51 Europe Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
52 Asia Pacific Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
53 Asia Pacific Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
54 Asia Pacific Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
55 Asia Pacific Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
56 Asia Pacific Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
57 Asia Pacific Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
58 Asia Pacific Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
59 Asia Pacific Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
60 Asia Pacific Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
61 Asia Pacific Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
62 Asia Pacific Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
63 Asia Pacific Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
64 Asia Pacific Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
65 Asia Pacific Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
66 Asia Pacific Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
67 Asia Pacific Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
68 Asia Pacific Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
69 South America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
70 South America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
71 South America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
72 South America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
73 South America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
74 South America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
75 South America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
76 South America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
77 South America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
78 South America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
79 South America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
80 South America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
81 South America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
82 South America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
83 South America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
84 South America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
85 South America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
86 Middle East & Africa Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
87 Middle East & Africa Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
88 Middle East & Africa Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
89 Middle East & Africa Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
90 Middle East & Africa Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
91 Middle East & Africa Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
92 Middle East & Africa Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
93 Middle East & Africa Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
94 Middle East & Africa Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
95 Middle East & Africa Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
96 Middle East & Africa Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
97 Middle East & Africa Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
98 Middle East & Africa Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
99 Middle East & Africa Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
100 Middle East & Africa Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
101 Middle East & Africa Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
102 Middle East & Africa Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials